Palomino Laboratories (PALX) EPS (Weighted Average and Diluted) (2023 - 2025)
Palomino Laboratories recorded quarterly EPS (Weighted Average and Diluted) of $0.41 in Q4 2025, up 175.74% quarter-over-quarter from -$0.54 in Q3 2025, and up 3818.18% year-over-year from $0.01 in Q4 2024.
Palomino Laboratories' EPS (Weighted Average and Diluted) history runs 3 years deep, the most recent figure standing at $0.41 for Q4 2025.
- In Q4 2025, EPS (Weighted Average and Diluted) rose 3818.18% year-over-year to $0.41; the TTM figure through Dec 2025 stood at -$0.58 (down 2048.15% YoY), while the FY2025 annual figure was -$0.47, down 4181.82% from the prior year.
- EPS (Weighted Average and Diluted) came in at $0.41 for Q4 2025 at Palomino Laboratories, up from -$0.54 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.41 in Q4 2025 to a low of -$0.54 in Q3 2025.
- A 3-year average of -$0.05 and a median of -$0.01 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 3818.18% in 2025 and fell as far as 773800.83% in 2025.
- Palomino Laboratories' EPS (Weighted Average and Diluted) stood at -$0.01 in 2023, then sank by 57.14% to -$0.01 in 2024, then jumped by 3818.18% to $0.41 in 2025.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered $0.41, -$0.54, and -$0.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | -0.54 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |